GeneNews Ltd (TSE:GEN) shares dropped 7.7% during mid-day trading on Tuesday . The company traded as low as C$0.12 and last traded at C$0.12. Approximately 257,950 shares traded hands during trading, a decline of 83% from the average daily volume of 1,549,548 shares. The stock had previously closed at C$0.13.
The stock has a market cap of $21.45 million and a PE ratio of -1.62.
About GeneNews (TSE:GEN)
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Further Reading: How can investors find ex-dividend dates?
Receive News & Ratings for GeneNews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews and related companies with MarketBeat.com's FREE daily email newsletter.